BioCentury
ARTICLE | Company News

GVK Biosciences Pte. Ltd., Wyeth deal

June 2, 2008 7:00 AM UTC

GVK will use its discovery chemistry, informatics, biology and ADME technologies to discover compounds against undisclosed targets for Wyeth’s Wyeth Pharmaceuticals division. GVK will receive an undis...